Drug Shortage Report for UROMITEXAN
Report ID | 228511 |
Drug Identification Number | 02241411 |
Brand name | UROMITEXAN |
Common or Proper name | Mesna Injection |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | MESNA |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL INTRAVENOUS ORAL INTRAVENOUS |
Packaging size | 2639B2019 - 400 mg (100 mg/mL) – 15 units/case |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-05-24 |
Actual start date | 2024-05-24 |
Estimated end date | 2024-06-10 |
Actual end date | 2024-06-10 |
Shortage status | Resolved |
Updated date | 2024-06-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-06-11 | French | Compare |
v6 | 2024-06-11 | English | Compare |
v5 | 2024-06-07 | French | Compare |
v4 | 2024-06-07 | English | Compare |
v3 | 2024-05-25 | English | Compare |
v2 | 2024-05-23 | French | Compare |
v1 | 2024-05-23 | English | Compare |
Showing 1 to 7 of 7